[1]
|
Romano, F., Cozzi, E., Airaldi, M., et al. (2023) Ten-Year Incidence of Fibrosis and Risk Factors for Its Development in Neovascular Age-Related Macular Degeneration. American Journal of Ophthalmology, 252, 170-181. https://doi.org/10.1016/j.ajo.2023.03.033
|
[2]
|
Spaide, R.F., Jaffe, G.J., Sarraf, D., et al. (2020) Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data. Ophthalmology, 127, 616-636. https://doi.org/10.1016/j.ophtha.2019.11.004
|
[3]
|
Keane, P.A., Patel, P.J., Liakopoulos, S., et al. (2012) Evaluation of Age-Related Macular Degenerationith Optical Coherence Tomography. Survey of Ophthalmology, 57, 389-414. https://doi.org/10.1016/j.survophthal.2012.01.006
|
[4]
|
Cohen, S.Y., Oubraham, H., Uzzan, J., et al. (2012) Causes of Unsuccessful Ranibizumab Treatment in Exudative Age-Related Macular Degeneration in Clinical Settings. Retina, 32, 1480-1485. https://doi.org/10.1097/IAE.0b013e318240a516
|
[5]
|
Bhutto, I. and Lutty, G. (2012) Understanding Age-related Macular Degeneration (AMD): Relationships between the Photoreceptor/Retinal Pigment Epithelium/Bruch’s Membrane/Choriocapillaris Complex. Molecular Aspects of Medicine, 33, 295-317. https://doi.org/10.1016/j.mam.2012.04.005
|
[6]
|
Toth, L.A., Stevenson, M. and Chakravarthy, U. (2015) Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration: Outcomes in Eyes with Poor Initial Vision. Retina, 35, 1957-1963. https://doi.org/10.1097/IAE.0000000000000583
|
[7]
|
Daniel, E., Toth, C.A., Grunwald, J.E., et al. (2014) Risk of Scar in the Comparison of Age-Related Macular Degeneration Treatments Trials. Ophthalmology, 121, 656-666. https://doi.org/10.1016/j.ophtha.2013.10.019
|
[8]
|
Koh, A., Lanzetta, P., Lee, W.K., et al. (2017) Recommended Guidelines for Use of Intravitreal Aflibercept with a Treat-and-Extend Regimen for the Management of Neovascular Age-Related Macular Degeneration in the Asia-Pacific Region: Report from a Consensus Panel. The Asia-Pacific Journal of Ophthalmology, 6, 296.
|
[9]
|
Amoaku, W., Balaskas, K., Cudrnak, T., et al. (2018) Initiation and Maintenance of a Treat-and-Extend Regimen for Ranibizumab Therapy in Wet Age-Related Macular Degeneration: Recommendations from the UK Retinal Outcomes Group. Clinical Ophthalmology, 12, 1731-1740. https://doi.org/10.2147/OPTH.S174560
|
[10]
|
Ryu, C.L., Al-humaid, S., Rampakakis, E., et al. (2016) Correlation of Visual Acuity with Fibrotic Scar Location in Neovascular Age-Related Degeneration Eyes. Retina, 36, 1324-1330. https://doi.org/10.1097/IAE.0000000000000877
|
[11]
|
Xiao, H., Zhao, X., Li, S., et al. (2021) Risk Factors for Subretinal Fibrosis after Anti-VEGF Treatment of Myopic Choroidal Neovascularization. British Journal of Ophthalmology, 105, 103-108. https://doi.org/10.1136/bjophthalmol-2019-315763
|
[12]
|
Cabello-Verrugio, C., Santander, C., Cofré, C., et al. (2012) The Internal Region Leucine-Rich Repeat 6 of Decorin Interacts with Low Density Lipoprotein Receptor-Related Protein-1, Modulates Transforming Growth Factor (TGF)-β-dependent Signaling, and Inhibits TGF-β-dependent Fibrotic Response in Skeletal Muscles. The Journal of Biological Chemistry, 287, 6773-6787. https://doi.org/10.1074/jbc.M111.312488
|
[13]
|
Barikian, A., Mahfoud, Z., Abdulaal, M., et al. (2015) Induction with Intravitreal Bevacizumab Every Two Weeks in the Management of Neovascular Age-Related Macular Degeneration. American Journal of Ophthalmology, 159, 131-137. https://doi.org/10.1016/j.ajo.2014.10.005
|
[14]
|
Tang, G., Li, S., Zhang, C., et al. (2021) Clinical Efficacies, Underlying Mechanisms and Molecular Targets of Chinese Medicines for Diabetic Nephropathy Treatment and Management. Acta Pharmaceutica Sinica B, 11, 2749-2767. https://doi.org/10.1016/j.apsb.2020.12.020
|
[15]
|
Zhang, H., Yang, Y., Takeda, A., et al. (2013) A Novel Platelet-Activating Factor Receptor Antagonist Inhibits Choroidal Neovascularization and Subretinal Fibrosis. PLOS ONE, 8, e68173. https://doi.org/10.1371/journal.pone.0068173
|
[16]
|
Cui, W., Zhang, H. and Liu, Z.-L. (2014) Interleukin-6 Receptor Blockade Suppresses Subretinal Fibrosis in a Mouse Model. International Journal of Ophthalmology, 7, 194-197.
|
[17]
|
Hillebrandt, S., Wasmuth, H.E., Weiskirchen, R., et al. (2005) Complement Factor 5 Is a Quantitative Trait Gene That Modifies Liver Fibrogenesis in Mice and Humans. Nature Genetics, 37, 835-843. https://doi.org/10.1038/ng1599
|
[18]
|
Bloch, S.B. (2013) Implementation Studies of Ranibizumab for Neovascular Age-Related Macular Degeneration. Acta Ophthalmologica, 91, 1-22. https://doi.org/10.1111/aos.12272
|
[19]
|
Roberts, P.K., Zotter, S., Montuoro, A., et al. (2019) Identification and Quantification of the Angiofibrotic Switch in Neovascular AMD. Investigative Opthalmology & Visual Science, 60, 304-311. https://doi.org/10.1167/iovs.18-25189
|
[20]
|
Cheng, C.-K., Chen, S.-J., Chen, J.-T., et al. (2022) Optimal Approaches and Criteria to Treat-and-Extend Regimen Implementation for Neovascular Age-Related Macular Degeneration: Experts Consensus in Taiwan. BMC Ophthalmology, 22, Article No. 25. https://doi.org/10.1186/s12886-021-02231-8
|
[21]
|
Fleckenstein, M., Keenan, T.D.L., Guymer, R.H., et al. (2021) Age-Related Macular Degeneration. Nature Reviews Disease Primers, 7, Article No. 31. https://doi.org/10.1038/s41572-021-00265-2
|
[22]
|
Luo, L., Zhang, X., Hirano, Y., et al. (2013). Targeted Intraceptor Nanoparticle Therapy Reduces Angiogenesis and Fibrosis in Primate and Murine Macular Degeneration. ACS Nano, 7, 3264-3275. https://doi.org/10.1021/nn305958y
|
[23]
|
Daniel, E., Pan, W., Ying, G., et al. (2018). Development and Course of Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials. Ophthalmology, 125, 1037-1046. https://doi.org/10.1016/j.ophtha.2018.01.004
|